Silencing of human HTT by targeted CRISPR/dCas9-mediated epigenetic editing
{{output}}
BackgroundGene silencing is widely recognized as a promising therapeutic approach for dominant monogenic disorders. Current silencing strategies, many of which are transient, utilize RNA interference. Gene silencing may also be achieved through directed epigen... ...